Work

Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience

Year: 2021

Type: article

Study design: Clinical Trial

Source: Oral Oncology

DOI: 10.1016/j.oraloncology.2021.105566

Authors: Ari J. Rosenberg, Nishant Agrawal, Alexander Pearson, Zhen Gooi, Elizabeth Blair, John Cursio, Aditya Juloori, Daniel Ginat, Adam Howard, Jeffrey Chin, Sara Kochanny, Corey Foster, Nicole Cipriani, Mark Lingen, Evgeny Izumchenko, Tanguy Y. Seiwert, Daniel Haraf, Everett E. Vokes

Institutions: University of Chicago, Vanderbilt University Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: AstraZeneca, Celgene, National Institutes of Health, National Cancer Institute, National Institute of Dental and Craniofacial Research

Awards: G1391097410, G1945244547, A reasoned approach to combination therapy development in head and neck cancer, G2991606041, Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules, Cancer Center Support Grant

OpenAlex ID: W3206829939

FWCI: 3.478

Cites: 32

Cited by: 31

Related to: 10